SCHOTT Pharma AG & Co. KGaA (1SXP.F)
EUR 23.72
(0.08%)
EUR 23.72
(0.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 72.33 Million EUR | -3.31% |
| 2022 | 74.8 Million EUR | 1978.58% |
| 2021 | 3.59 Million EUR | -25.29% |
| 2020 | 4.81 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 93.72 Million EUR | 32.03% |
| 2024 Q2 | 70.98 Million EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2023 Q4 | 72.33 Million EUR | 0.0% |
| 2023 FY | 72.33 Million EUR | -3.31% |
| 2023 Q3 | - EUR | 0.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 FY | 74.8 Million EUR | 1978.58% |
| 2022 Q4 | 74.8 Million EUR | 0.0% |
| 2021 FY | 3.59 Million EUR | -25.29% |
| 2020 FY | 4.81 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Carl Zeiss Meditec AG | 155.69 Million EUR | 53.543% |
| Fielmann Aktiengesellschaft | 652.37 Million EUR | 88.913% |
| Gerresheimer AG | 1.04 Billion EUR | 93.054% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 98.638% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 98.638% |